Pharmacies across Britain are facing significant shortages of a commonly-used medication, putting patients at risk of heart attacks and strokes.
Pharmacists are expressing frustration over the NHS prescribing system, which hinders them from substituting prescriptions for suitable blood-thinning alternatives to aspirin. Aspirin, a widely-used painkiller, also serves as a blood thinner taken by a significant portion of the population, particularly by older individuals.
A recent survey conducted by the National Pharmacy Association (NPA) involving 540 UK community chemists revealed that a staggering 86% reported the inability to provide aspirin. The shortage is particularly severe for the 75mg dosage, affecting all variants. Some pharmacies have even halted over-the-counter sales of aspirin.
Olivier Picard, the chair of NPA, expressed concerns over the situation, emphasizing the potential implications for patient care. Long-term use of low-dose aspirin plays a crucial role in preventing blood clots, heart attacks, and strokes.
The NPA is advocating for reforms to the current regulations that restrict pharmacies from offering alternative medications when faced with supply shortages. Mr. Picard highlighted the risks associated with sending patients back to their doctors for prescription changes when safe alternatives are available in stock, emphasizing the importance of patient safety.
In response to the shortages, the Government has included aspirin in its export ban list to safeguard local supplies. Pharmacies are now rationing aspirin supplies, prioritizing patients with acute heart conditions or those requiring emergency prescriptions.
International manufacturing delays and supply chain issues have been cited as the primary causes of the shortages by the Independent Pharmacies Association. Moreover, the association noted that the UK’s lower pricing agreements with pharmaceutical companies often result in the country being deprioritized when limited stocks are available.
Despite the challenges, the Independent Pharmacies Association encourages patients in need of aspirin to consult their local pharmacists for information on suitable alternatives. The shortages have led to price increases for aspirin in pharmacies that managed to secure stocks.
The NPA reported a significant price hike for aspirin 75mg dispersible tablets, from 18p last year to £3.90 this month. Due to NHS reimbursement limitations, pharmacies are incurring losses with each dispensed packet. This situation underscores the urgent need for government intervention to reform the existing pharmacy contract.
Aspirin, a commonly used non-steroidal anti-inflammatory drug, not only relieves pain and reduces inflammation but also acts as an antiplatelet agent to prevent heart attacks and strokes. The increased prices and limited availability of aspirin pose challenges for pharmacies and patients alike.
Dr. Leyla Hannbeck stressed the importance of reviewing medication reimbursement policies to address the worsening shortages. Community Pharmacy England’s director of research and insights, James Davies, called for immediate intervention from the Government and the NHS to stabilize the medicines market and enhance access to essential medications for patients.
